OrganOx receives £4.6m investment from the British Growth Fund
The investment will fund the expansion of OrganOx’s first product, the Metra, in the US, building on commercial traction in Europe, Canada and Australia.
News & Insights
Dr Ian Gilham appointed as new Chair of Cytox
Ian started his career developing novel diagnostics at Celltech and has held further posts developing diagnostics at Amersham International, Abbott Laboratories and GlaxoSmithKline, before becoming CEO of Axis-Shield. During his tenure he managed the sale of the business to Alere in 2011 for £250m.
Oxehealth wins LaingBuisson’s Innovation in Technology award
The LaingBuisson Awards, often referred to as ‘the Oscars for Healthcare’, recognise and celebrate industry excellence in the UK health and social care services.
Sphere Fluidics wins 2019 IChemE Biotechnology Award
OTIF portfolio company Sphere Fluidics has been awarded the 2019 IChemE Biotechnology award for its role in a collaborative project optimising the discovery and development of cost-effective next generation biotherapeutics with Lonza Biologics, UCB Celltech, Horizon Discovery, Alcyomics Ltd and CPI.
Caristo Diagnostics wins ‘Best Start-up Medtech Company’ award 2019 Oxford Bioscience Network (OBN)
OBN is the not-for-profit Membership organisation supporting and bringing together the UK’s life sciences companies, corporate partners and investors. The Awards, which are in their 11th year, celebrate the best of UK life sciences.